Bulk Pharmaceutical API Sources for pyrimethamine

Bulk Pharmaceutical API Sources for pyrimethamine

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-001-783-655
Hangzhou APIChem Technology		AC-7879
Amadis Chemical		A831755
AKos Consulting & Solutions		AKOS015892534
Oakwood Products		211965
CAPOT		9611

Bulk Active Pharmaceutical Ingredient (API) Sources for: Pyrimethamine

Last updated: July 31, 2025

Introduction

Pyrimethamine is an antiprotozoal medication primarily used in the treatment and prevention of malaria and toxoplasmosis. As a folic acid antagonist, it inhibits dihydrofolate reductase, impairing DNA synthesis in protozoa. The demand for pyrimethamine has increased, driven by its essential role in infectious disease management, especially in regions with limited healthcare resources. Ensuring a reliable, high-quality supply chain for pyrimethamine API is critical for pharmaceutical manufacturers, healthcare providers, and global health initiatives. This article explores the current landscape of API sourcing options for pyrimethamine, examining key suppliers, sourcing strategies, quality considerations, and emerging trends.

Global API Manufacturing Landscape

The production of pyrimethamine API is concentrated among a limited number of regions, primarily due to the specialized chemical synthesis involved. Major manufacturing hubs include China, India, and certain European countries. These countries host both large-scale API producers and contract manufacturing organizations (CMOs) capable of supplying high-quality APIs compliant with regulatory standards such as API quality requirements of the World Health Organization (WHO), European Medicines Agency (EMA), and the U.S. Food and Drug Administration (FDA).

China

China remains a dominant player in the global API market, offering cost-effective solutions due to lower manufacturing costs and extensive chemical synthesis expertise. Numerous Chinese API manufacturers have established facilities compliant with Good Manufacturing Practices (GMP) and are approved by major regulatory bodies. Companies such as Zhejiang Hisun Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical, and North China Pharmaceutical Group (NCPC) produce pyrimethamine APIs for international markets.

India

India's pharmaceutical industry, known for its robust API manufacturing ecosystem, supplies pyrimethamine APIs through companies such as Aurobindo Pharma, Cipla, and Sun Pharmaceutical Industries. These firms benefit from a well-established GMP compliance infrastructure, competitive pricing, and extensive export networks.

Europe

European manufacturers are also involved, primarily providing specialized, high-quality APIs to meet stringent regulatory standards. Firms like Evonik Industries and TEVA Pharmaceuticals produce pyrimethamine APIs for countries with strict regulatory requirements, offering high purity and verified stability profiles.

API Suppliers for Pyrimethamine

A comprehensive understanding of API suppliers is essential for procurement strategies. Below is an overview of notable suppliers categorized by region.

Chinese API Manufacturers

• Zhejiang Hisun Pharmaceutical Co. Ltd.
  Offers GMP-compliant pyrimethamine API with a focus on cost competitiveness and supply volume flexibility.

• North China Pharmaceutical Group (NCPC)
  Known for extensive research and manufacturing capabilities, NCPC provides APIs adhering to international standards.

• Hubei Huamu Biological Technology Co. Ltd.
  Specializes in sourcing APIs for infectious disease treatments, including pyrimethamine, with emphasis on quality control.

Indian API Manufacturers

• Aurobindo Pharma
  Provides high-quality pyrimethamine APIs for global markets, with proven compliance with WHO and EMA standards.

• Cipla Ltd.
  Offers APIs with robust quality assurance processes, supporting various formulations across regions.

• Jubilant Life Sciences
  Supplies pyrimethamine API with a focus on seamless scaling and regulatory compliance.

European API Manufacturers

• Evonik Industries
  Produces specialty APIs with a focus on high purity and tailored formulations.

• TEVA Pharmaceuticals
  Supplies APIs meeting rigorous European regulatory standards, with emphasis on documentation and batch consistency.

Other Notable Suppliers

• Alpharm Ltd. (South Korea)
  Specializes in antimicrobial and antiparasitic APIs, including pyrimethamine, supporting regional and international markets.

• Pharmaceuticals in the United States
  Limited direct manufacturing, often reliance on imported APIs from Chinese and Indian suppliers, though some US-based CMOs offer domestic sourcing options.

Quality and Regulatory Considerations

Sourcing high-quality pyrimethamine API demands rigorous quality control, including stability, purity, bioavailability, and compliance with international Good Manufacturing Practices. Manufacturers should obtain Certificates of Analysis (CoA), Batch Production Records, and regulatory approvals to ensure consistency and safety. Regulatory agencies increasingly scrutinize the supply chain, demanding detailed documentation, transparent manufacturing processes, and evidence of WHO prequalification where applicable.

Emerging Trends and Sourcing Strategies

Shift Toward Diversification

To mitigate supply chain risks, pharmaceutical companies are diversifying API sources. Relying exclusively on one region or supplier exposes firms to geopolitical, logistical, or regulatory disruptions. A balanced approach involves establishing multiple qualified suppliers across regions to ensure supply continuity.

Contract Manufacturing and Licensing Agreements

Many companies engage CMOs for pyrimethamine API manufacturing to leverage existing GMP compliance, reduce capital expenditure, and accelerate time-to-market. Strategic licensing and long-term partnerships enhance supply stability and quality assurance.

Focus on API Sustainability and Green Chemistry

Emerging trends emphasize sustainable manufacturing practices, reducing environmental impact. Suppliers adopting green chemistry principles are increasingly favored, aligning with global regulatory expectations and corporate responsibility standards.

Digitalization and Supply Chain Transparency

Advanced tracking systems, blockchain technology, and real-time monitoring are improving supply chain transparency, enabling stakeholders to verify API authenticity, origin, and compliance swiftly.

Impact of International Regulations

Regulatory frameworks like the FDA’s Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (FMD) influence sourcing decisions, emphasizing validated supply chains and traceability.

Concluding Remarks

The landscape for pyrimethamine API sourcing is characterized by a global network of manufacturers, primarily in China, India, and Europe, offering diverse options tailored to varying quality and cost requirements. Strategic sourcing involves balancing cost-effectiveness with regulatory compliance, supply stability, and quality assurance. As infectious disease management remains critical, especially in resource-limited settings, ensuring access to reliable, high-quality pyrimethamine API will continue to be a priority for pharmaceutical stakeholders.

---

Key Takeaways

• Global Supply Network: China and India dominate pyrimethamine API production, supported by European manufacturers focusing on high-quality standards.
• Quality Assurance: Rigorous adherence to GMP, detailed documentation, and regulatory compliance are vital for supplier selection.
• Diversification Strategy: Multiple supplier relationships mitigate risks associated with geopolitical or supply disruptions.
• Emerging Trends: Sustainability, digital transparency, and strategic partnerships are shaping the future of API sourcing.
• Regulatory Impact: Compliance with global standards, including WHO prequalification and regional regulations, influences sourcing choices.

---

FAQs

1. What are the major regions supplying pyrimethamine API globally?

China, India, and Europe are the primary regions, with China and India being the dominant cost-effective manufacturing hubs, and Europe providing high-purity, regulatory-compliant APIs.

2. How can buyers ensure the quality of pyrimethamine APIs?

Verification through Certificates of Analysis, GMP compliance certification, regulatory approvals, and audit reports ensures quality. Establishing long-term relationships with accredited suppliers further mitigates risks.

3. Are there specific regulatory certifications required for pyrimethamine API sourcing?

Yes. Suppliers should have GMP certification, be compliant with WHO guidelines, and possess regulatory approvals from relevant authorities such as the FDA, EMA, or local regulatory bodies.

4. What risks are associated with relying solely on a single supplier for pyrimethamine API?

Dependent sourcing from a single supplier exposes manufacturers to risks like supply shortages, quality inconsistencies, geopolitical disruptions, and regulatory compliance issues.

5. How are emerging trends impacting pyrimethamine API procurement?

Trends like supplier diversification, green chemistry practices, and digital supply chain transparency are enhancing security, sustainability, and compliance in API procurement.

---

References

[1] World Health Organization. (2021). Prequalification of Medicines Programme. https://www.who.int/groups/prequalification-of-vaccines-and-medicines
[2] U.S. Food and Drug Administration. (2022). Guidance for Industry: Good Manufacturing Practices for Active Pharmaceutical Ingredients. https://www.fda.gov
[3] European Medicines Agency. (2022). Guideline on quality of active substances. https://www.ema.europa.eu
[4] GlobalData. (2023). Pharmaceutical APIs Market Report.
[5] IQVIA Institute. (2022). The Global Use of Medicines in 2022.